Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates

about

Cystic fibrosis, pathophysiological and clinical aspects.Cystic fibrosis: a review of pulmonary infections and interventions.In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.Sensitivity of 523 blood culture isolates to 33 antibiotics.

P2860

Q37977706-13364F40-C939-4B3E-9DE8-C1CDAD9E8C79 Q39675635-BA16D74A-A431-461D-BE5C-BDBDE423B1DD Q44632608-EF0AB0BB-C563-498A-A64E-8813B8D9E14E Q54482265-90CB67B0-06F3-4206-B294-A6FCBACC609B

P2860

Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates

Item

http://www.wikidata.org/entity/Q35713674

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年論文

@yue

1982年論文

@zh-hant

1982年論文

@zh-hk

1982年論文

@zh-mo

1982年論文

@zh-tw

1982年论文

@wuu

1982年论文

@zh

1982年论文

@zh-cn

name

Comparative in vitro activitie ...... g resistant bacterial isolates

@ast

Comparative in vitro activitie ...... g resistant bacterial isolates

@en

type

Item

label

Comparative in vitro activitie ...... g resistant bacterial isolates

@ast

Comparative in vitro activitie ...... g resistant bacterial isolates

@en

prefLabel

Comparative in vitro activitie ...... g resistant bacterial isolates

@ast

Comparative in vitro activitie ...... g resistant bacterial isolates

@en

P1476

Comparative in vitro activitie ...... g resistant bacterial isolates

@en

P2093

Fass RJ

http://www.w3.org/2001/XMLSchema#string

P2860

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.

Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics.

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.

In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.

Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.

In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Activity of mecillinam alone and in combination with other beta-lactam antibiotics.

Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients.

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

P304

167-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.22.1.167

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1982-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16906020

http://www.w3.org/2001/XMLSchema#string

P698

6289737

http://www.w3.org/2001/XMLSchema#string

P921

azlocillin

multiple drug resistance

P932

183696

http://www.w3.org/2001/XMLSchema#string

Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates

about

P2860

P2860

Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932